Xerium Celebrates 1000th Formsoft Tissue Forming Fabric
YOUNGSVILLE, NC, September 1, 2015 (BUSINESS WIRE) -- Xerium Technologies, Inc. (NYSE:XRM), a leading global provider of industrial consumable products and services, recently celebrated the shipment of its 1000th Formsoft tissue forming fabric at its Kentville, Canada plant. The globally successful and patented Formsoft technology has enabled tissue makers to produce their products with higher quality and at increased efficiency. Formsoft is one of the fastest growing products the company has ever launched into the market.
“Formsoft continues to provide our customers with excellent machine speeds and outstanding sheet softness,” said Mr. Bill Butterfield, EVP and CTO of Xerium. “Like our other innovations, Xerium has developed Formsoft technology to benefit its customers by lowering their operational cost while improving operational performance and overall efficiency. This unique tissue fabric, with patented warp and weft structure, consistently delivers top drainage performance for a stronger, yet softer, tissue product. It combines improved sheet forming and fiber retention benefits with high dimensional stability and life potential resulting in optimized tissue machine runnability.”
Xerium Technologies, Inc. (NYSE:XRM) is a leading global provider of industrial consumable products and services. Xerium, which operates around the world under a variety of brand names, utilizes a broad portfolio of patented and proprietary technologies to provide customers with tailored solutions and products integral to production, all designed to optimize performance and reduce operational costs. With 27 manufacturing facilities in 13 countries around the world, Xerium has approximately 3,100 employees.
This press release contains forward-looking statements. The words “believe,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Actual results may differ materially from these forward-looking statements and estimates as a result of various important factors, including, without limitation, the factors discussed in our annual report on Form 10-K for the fiscal year ended December 31, 2014, which is on file with the SEC and is available in the investor relations section of our website at www.xerium.com. Any forward-looking statements are as of the date hereof, and we assume no obligation to publicly update or revise these forward-looking statements for any reason, whether as a result of new information, future events, or otherwise, except as may be required by law.
Director – Global Marketing
Source: Xerium Technologies, Inc.